Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ISRG

Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today

Intuitive Surgical stock sinks as FDA announces marketing authorization for Johnson & Johnson’s Ottava platform. Here’s why the news is largely bearish for ISRG shares.

Barchart

Why Intuitive Surgical’s Strong Quarter Still Spooked Investors

Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.

MarketBeat

ISRG Stock Sinks as Analysts Cut Price Targets on Intuitive Surgical

Intuitive Surgical stock sinks as muted guidance triggers a wave of Wall Street price cuts. But ISRG shares may still be worth buying on the dip.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Stock Market Today: Dow, Nasdaq, S&P 500 Futures Slump as Trump Says U.S. Is Going 'Great'— Netflix, Coca-Cola, Nebius in Focus (UPDATED)

(Editor’s note: The ETFs and economic data were updated.)

Benzinga

TSMC Could Swing $150 Billion as Options Market Prices Big Moves for This Week’s Earnings

Earnings season kicks into high gear next week, with a slate of heavyweight companies set to report quarterly results between July 12 and July 18. As investors look for fresh insight into corporate earnings, guidance and the broader economic backdrop, options traders are already betting on how sharply these stocks…

Benzinga

Intuitive Surgical’s Quarterly Earnings Preview: What You Need to Know

Intuitive Surgical is approaching a pivotal earnings update as strong forecasts square off against a stock that has lost its footing.

Barchart

Is Baxter International Stock Underperforming the S&P 500?

Due to Baxter International's underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Align Technology Stock Underperforming the Dow?

While Align Technology has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Becton, Dickinson and Company Stock: Is BDX Underperforming the Healthcare Sector?

Although Becton, Dickinson and Company has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Intuitive Surgical Stock: Is ISRG Underperforming the Healthcare Sector?

Despite recent underperformance relative to the healthcare sector, analysts remain fairly bullish on Intuitive Surgical's long-term fundamentals and growth potential.

Barchart

Are Wall Street Analysts Bullish on Intuitive Surgical Stock?

While Intuitive Surgical has notably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Does Intuitive Surgical Have More Room to Run After Q1 Beat?

Intuitive Surgical stock rallied on a strong Q1 and encouraging future guidance. Piper Sandler analysts reiterated their bullish stance on ISRG shares.

Barchart

Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity

Intuitive Surgical is the leading robotic surgery stock, outpacing consensus estimates and cementing its first-mover status.

MarketBeat

Intuitive Surgical's Q1 2026 Earnings: What to Expect

Intuitive Surgical is scheduled to report its first-quarter results soon, and analysts expect a double-digit earnings rise.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

1 Stock To Buy, 1 To Stay Away From in 2026

One high-quality growth stock to own in 2026 and one that may struggle to keep up.

Barchart

What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?

Although Intuitive Surgical has lagged the broader market over the past year, analysts remain broadly bullish on the company’s long-term growth outlook.

MarketBeat

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional biotech risk

MarketBeat

2 Healthcare Names That Could Get a Big Boost From Earnings

Both Abbott Laboratories and Intuitive Surgical report fourth-quarter results in late January—and both companies offer investors multiple reasons to be bullish.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Intuitive Surgical Earnings Preview: What to Expect

Intuitive Surgical is set to release its fourth-quarter results next month, and analysts are forecasting a modest, single-digit decline in earnings.

Barchart

Is ResMed Stock Underperforming the S&P 500?

Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

Is Intuitive Surgical Stock Underperforming the Nasdaq?

Intuitive Surgical has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Intuitive Surgical Stock: Is Wall Street Bullish or Bearish?

While Intuitive Surgical has underperformed the broader market this past year, analysts maintain a fairly bullish stance on its future prospects.

MarketBeat

$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS

Are Intuitive Surgical insiders cashing out after its October earnings surge? See the signals insiders are sending at KMI, ISRG, and QuantumScape.

MarketBeat

Top 3 Stocks Powering Through Trump’s Tariff Policies

While tariffs were once the bane of their existence, General Motors, Apple, and Intuitive Surgical have come roaring back from "Liberation Day"-induced lows.

Benzinga

Intuitive Surgical Q3 Results Ease Bear Market Concerns, Analyst Views 'Headwinds As Largely Noise'

Intuitive Surgical (NASDAQ:ISRG) reported revenue of $2.51 billion for the third quarter, up 23% year-over-year, beating analyst estimates of $2.40 billion.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.